NO20063937L - Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis - Google Patents

Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis

Info

Publication number
NO20063937L
NO20063937L NO20063937A NO20063937A NO20063937L NO 20063937 L NO20063937 L NO 20063937L NO 20063937 A NO20063937 A NO 20063937A NO 20063937 A NO20063937 A NO 20063937A NO 20063937 L NO20063937 L NO 20063937L
Authority
NO
Norway
Prior art keywords
psoriasis
treatment
isoleucine
serine
composition
Prior art date
Application number
NO20063937A
Other languages
English (en)
Inventor
Thomas Tallberg
Original Assignee
Helsingfors Institution For Bi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsingfors Institution For Bi filed Critical Helsingfors Institution For Bi
Publication of NO20063937L publication Critical patent/NO20063937L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Biologiske medisinske anordninger for behandling av psoriasis er beskrevet. Oppfinnelsen vedrører anvendelsen av L-serin (Ser) og L-isoleucin (Ile) for fremstillingen av en farmasøytisk sammensetning for behandling eller forebygging av psoriasis. Oppfinnelsen vedrører videre en farmasøytisk sammensetning omfattende aminosyrene som aktive ingredienser. Fortrinnsvis omfatter sammensetningen videre minst ett vesentlig sporelement valgt fra gruppen bestående av krom (Cr), tinn (Sn), selen (Se), vanadium (V), wolfram (W) og sink (Zn) og folsyre.
NO20063937A 2004-02-06 2006-09-04 Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis NO20063937L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040180A FI121915B (fi) 2004-02-06 2004-02-06 Koostumus psoriasiksen hoitoon
PCT/FI2005/000075 WO2005074910A1 (en) 2004-02-06 2005-02-04 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis

Publications (1)

Publication Number Publication Date
NO20063937L true NO20063937L (no) 2006-09-04

Family

ID=31725662

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20063937A NO20063937L (no) 2004-02-06 2006-09-04 Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis

Country Status (17)

Country Link
US (1) US20070258892A1 (no)
EP (1) EP1718290B1 (no)
JP (1) JP4919812B2 (no)
CN (1) CN1917868B (no)
AT (1) ATE466576T1 (no)
AU (1) AU2005210181B2 (no)
BR (1) BRPI0507732A (no)
CA (1) CA2555328C (no)
DE (1) DE602005021062D1 (no)
DK (1) DK1718290T3 (no)
ES (1) ES2344510T3 (no)
FI (1) FI121915B (no)
NO (1) NO20063937L (no)
PL (1) PL1718290T3 (no)
PT (1) PT1718290E (no)
RU (1) RU2372899C2 (no)
WO (1) WO2005074910A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI122450B (fi) * 2007-12-28 2012-01-31 Neurofood Ab Oy Koostumus steriilin inflammaation hoitoon
FR2947452B1 (fr) 2009-07-01 2012-04-20 Fabre Pierre Dermo Cosmetique L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
CN101953846B (zh) * 2010-06-24 2011-12-28 攀枝花兴辰钒钛有限公司 一种药物组合物在制备治疗糖尿病的药物中的用途
EP2782566B1 (en) 2011-11-21 2021-01-06 The Institute for Ethnomedicine L-serine as for use in treating neurodegenerative disorders
EP3586849A1 (en) * 2018-06-29 2020-01-01 Aprofol AG Folate preparations
AU2020334128B2 (en) * 2019-08-21 2025-10-23 Brain Chemistry Labs Compositions comprising a metal and L-serine, and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83775A (en) * 1987-09-04 1991-12-15 Dexter Chemical Corp Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
DE3712986A1 (de) * 1987-04-16 1988-10-27 Marbert Gmbh Medizinische zubereitungen auf der grundlage von biertreberextrakt, verfahren zu deren herstellung sowie verwendung von biertreberextrakt zur herstellung von kosmetischen zubereitungen und ein spezieller biertreberextrakt
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
CN1080131A (zh) * 1993-04-28 1994-01-05 王韵三 一种美容保健营养食品和制备方法
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
RU2071777C1 (ru) * 1995-01-13 1997-01-20 Тамара Васильевна Воробьева Способ получения средства, обладающего противоопухолевой активностью
US6083293A (en) * 1997-02-24 2000-07-04 Bath; Virginia L. Method for enhanced plant protein production and composition for use in the same
IT1299623B1 (it) * 1998-02-23 2000-03-24 Gen Topics Srl Composizione per uso cosmetico o farmaceutico a base di acido lipoico e acido piruvico
WO1999055321A1 (en) * 1998-04-24 1999-11-04 Mitokor Compounds and methods for treating mitochondria-associated diseases
GB0019327D0 (en) * 2000-08-08 2000-09-27 Buchanan Baillie Hamilton Paul Slimming system
US20040086583A1 (en) * 2002-11-01 2004-05-06 Jensen Claude Jarakae Anti-angiogenesis effects of morinda citrifolia

Also Published As

Publication number Publication date
CN1917868B (zh) 2010-09-01
PT1718290E (pt) 2010-07-01
RU2006128209A (ru) 2008-03-20
WO2005074910A1 (en) 2005-08-18
FI121915B (fi) 2011-06-15
HK1097455A1 (en) 2007-06-29
FI20040180L (fi) 2005-08-07
JP2007520532A (ja) 2007-07-26
FI20040180A0 (fi) 2004-02-06
DK1718290T3 (da) 2010-08-02
CA2555328A1 (en) 2005-08-18
ATE466576T1 (de) 2010-05-15
AU2005210181B2 (en) 2010-05-20
US20070258892A1 (en) 2007-11-08
ES2344510T3 (es) 2010-08-30
EP1718290B1 (en) 2010-05-05
JP4919812B2 (ja) 2012-04-18
BRPI0507732A (pt) 2007-07-10
AU2005210181A1 (en) 2005-08-18
EP1718290A1 (en) 2006-11-08
DE602005021062D1 (de) 2010-06-17
CN1917868A (zh) 2007-02-21
RU2372899C2 (ru) 2009-11-20
CA2555328C (en) 2013-03-26
PL1718290T3 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
NO20072542L (no) Pyrimidinderivat kondensert med ikke-aromatisk ring
WO2007061661A4 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
NO20064584L (no) Tetrahydropyridoindolderivater
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
SE0301010D0 (sv) Novel compounds
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
NO20054769L (no) Substituerte fenylalkansyrer
NO20050932L (no) 1-pyridin-4-yl-ureaderivater
SE0403006D0 (sv) New compounds
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
NO20063937L (no) Sammensetning omfattende L-serin, L-isoleucin, folsyre og sporelementer for behandling av psoriasis
ATE422201T1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
BRPI0801239A2 (pt) uso de um ou mais benzopiranonas, composição farmacêutica e método de prevenção ou tratamento de doenças, disfunções e distúrbios associados a monoamino oxidase
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
MX337606B (es) Metodo y composiciones farmaceuticas para el tratamiento de la hiperglicemia postprandial de la diabetes tipo ii, a traves de la mucosa bucal.
DE50312224D1 (de) Deuterierte catecholaminderivate sowie diese verbindungen enthaltende arzneimittel
TW200745081A (en) Compounds
NO20073710L (no) Kjemiske forbindelser
DK1824501T3 (da) Proteinhydrolysat med antidiabetisk virkning
TW200728281A (en) Novel N-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions
DE602006008788D1 (de) Verbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application